15 results on '"Cabergoline -- Research"'
Search Results
2. New Dopaminergic Antiparkinsonism Agents Study Findings Recently Were Reported by Researchers at University of Basel (OATP1A2 and OATP2B1 Are Interacting with Dopamine-Receptor Agonists and Antagonists)
3. Shaheed Beheshti University of Medical Sciences Researchers Update Current Study Findings on Lactation Disorders (Idiopathic granulomatous hypophysitis presenting with galactorrhea, headache, and nausea in a woman: a case report and review of ...)
4. Findings on Endocrinology Reported by Researchers at Kocaeli University (Metastatic MEN1 Syndrome Treated with Lutetium-177 - A Case Report)
5. Findings from University of Oxford Provide New Insights into Dopamine Receptors (Dopamine D2 receptor stimulation modulates the balance between ignoring and updating according to baseline working memory ability)
6. New Dopaminergic Antiparkinsonism Agents Study Results Reported from Payame Noor University (Disposable Electrochemical Sensor Based On Modified Screen Printed Electrode for Sensitive Cabergoline Quantification)
7. Data from H. Lasolle et al Provide New Insights into Acromegaly (Pasireotide-LAR in acromegaly patients treated with a combination therapy: a real-life study)
8. Research Results from Department of Pharmacy Update Understanding of HIV/AIDS (Cabergoline: a review of its use in the inhibition of lactation for women living with HIV)
9. Data on Prolactinoma Detailed by Researchers at Nanjing University (Bromocriptine and Cabergoline Induce Cell Death In Prolactinoma Cells Via the Erk/egr1 and Akt/mtor Pathway Respectively)
10. Study Data from Hospital Clinic Update Knowledge of Pituitary Adenoma (Cabergoline In the Management of Residual Nonfunctioning Pituitary Adenoma a Single-center, Open-label, 2-year Randomized Clinical Trial)
11. New Findings from University of Tokyo Hospital Yields New Data on Adenomas (A case of functioning gonadotroph adenoma in a reproductive aged woman)
12. Studies from Yonsei University Yield New Data on Dopaminergic Antiparkinsonism Agents (Prolactin <= 1 Ng/ml Predicts Macroprolactinoma Reduction After Cabergoline Therapy)
13. Studies in the Area of Prolactinoma Reported from University of Sao Paulo (Prolactinomas in pregnancy: considerations before conception and during pregnancy)
14. Recent Findings by V.VC. Sinatti and Colleagues in Metabolic Engineering Provides New Insights (Identification of metabolites identical and similar to drugs as candidates for metabolic engineering)
15. Studies from Endocrinology Unit Provide New Data on Menopause (Cabergoline Withdrawal Before and After Menopause: Outcomes in Microprolactinomas)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.